(Q37806066)

23 August 2017

title

The great debate: haploidentical or cord blood transplant (English)

1 reference

23 August 2017

K K Ballen

1

1 reference

23 August 2017

T R Spitzer

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

Bone Marrow Transplantation

23 August 2017

published in

1 reference

23 August 2017

volume

46

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

323-329

1 reference

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Targeting the Warburg effect in hematological malignancies: from PET to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of thymopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Current status of haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

HLA-haploidentical stem cell transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: estab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Marrow transplantation from related donors other than HLA-identical siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

The haploidentical option for high-risk haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.260

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.260

1 reference

23 August 2017

1 reference